{"ticker": {"uuid": "869ebde0-6a03-4e36-bf0e-afe9f9df4ec0", "symbol": "TWST", "name": "Twist Bioscience Corp", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Twist Bioscience Is Maintained at Buy by Canaccord Genuity", "summary": "Canaccord Genuity has maintained its \"Buy\" rating for Twist Bioscience (TWST). The article briefly mentions unrelated fourth-quarter financial results for Unity Software, which exceeded revenue estimates but reported a loss per share.", "url": "https://www.moomoo.com/news/post/72935284/twist-bioscience-is-maintained-at-buy-by-canaccord-genuity", "source_name": "Moomoo", "published_at": "2026-07-15T14:46:43", "published_display": "15 Jul 2026 14:46", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience plans 8 a.m. ET call for fiscal Q3 update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOd0ZkWmNRZVREUnFxQW5iU1BVYmlDaEtucmU1cUpQUC1Fb05QU0dkUW54dHFXQkpvMjYtWE1NV3ZkYzdCSm9ZQ0tGR2pHLXNpX2JsVTFfbUE3TmhDZU1HSlhlRVBSQTJETml1MFVBSzRtX0M5TWhNQjdxQ1NLVE41aTlOWlM4OG4zYXZlb2J6cGY5T3lqRmNEem14OGs3ak1SRURfWUJLLXMyMjNkei02YVV6WFU3SU5D?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026", "summary": "Twist Bioscience Corporation (NASDAQ: TWST) announced it will release its fiscal 2026 third-quarter financial results before market open on August 3, 2026. The company will also host a conference call and live audio webcast for analysts and investors at 8:00 AM ET on the same day", "url": "https://sg.finance.yahoo.com/news/twist-bioscience-report-fiscal-2026-120000638.html", "source_name": "Market source", "published_at": "2026-07-15T11:46:43", "published_display": "15 Jul 2026 11:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST Maintained by Canaccord Genuity -- Price Target Raised to $120", "summary": "Canaccord Genuity maintained a 'Buy' rating for Twist Bioscience (TWST) and raised its price target to $120, citing a positive outlook on the company's growth potential despite its current overvalued status according to GuruFocus. While analysts are optimistic due to Twist Biosci", "url": "https://www.gurufocus.com/news/8957540/twst-maintained-by-canaccord-genuity-price-target-raised-to-120", "source_name": "GuruFocus", "published_at": "2026-07-14T13:41:07", "published_display": "14 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CFO Adam Laponis sells $226,307 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPN21EaFVhY2U1V0Z2ZHpZYmZzMzUwbFRFb3lYeU1EWkg5SE1BaDVaQlhUYm5JS0NTOW9jSWp4cncyZDNDSXFnQlptTzc5ekg5Nm53V2VPdW1yc3FZQ1pCWFIwRnZYT0xqT0dWZzRoLS16UHJkSFVwTkJFX3QtajhpbndhYTRGcEhrTFRheU5ZbldqSE5CaUR1c2ZhNmd5NEZzVTZ5YkhTZWc4TGJjNGRndjVBLTdfUk0?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-13T21:41:47+00:00", "published_display": "13 Jul 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Twist Bioscience Corp Insider Trading Activity", "summary": "Twist Bioscience Corp's CFO, Adam Laponis, sold 2,399 shares of common stock on July 9, 2026, for $94.334 per share. This \"sell to cover\" transaction was mandatory to meet tax withholding obligations from vesting Restricted Stock Units, not a discretionary sale. Following the sal", "url": "https://www.stocktitan.net/sec-filings/TWST/form-4-twist-bioscience-corp-insider-trading-activity-5f5f896b5d1f.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CFO Adam Laponis sells $226,307 in stock", "summary": "Twist Bioscience CFO Adam Laponis sold $226,307 worth of company stock to cover tax obligations related to Restricted Stock Units, not as a discretionary trade. This transaction occurred as the stock experienced a 9.3% decline over the past week and is considered overvalued by In", "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-cfo-adam-laponis-sells-226307-in-stock-93CH-4789172", "source_name": "Investing.com", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Twist Bioscience Corp For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Twist Bioscience Corp (TWST) on July 13. Form 4 filings are used to report changes in beneficial ownership of company stock by insiders. The article provides the date of the filing and mentions Twist Bioscience Corp's stock symbol.", "url": "https://ca.investing.com/news/stock-market-news/form-4-twist-bioscience-corp-for-13-july-93CH-4731757", "source_name": "Investing.com Canada", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) price target increased by 20.55% to 64.90", "summary": "This article reports a significant increase in Twist Bioscience's (TWST) price target. The target has been raised by 20.55% to $64.90.", "url": "http://www.msn.com/en-us/money/top-stocks/twist-bioscience-twst-price-target-increased-by-20-55-to-64-90/ar-AA23cZSC?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-11T22:40:50", "published_display": "11 Jul 2026 22:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Twist Bioscience\u2019s (TWST) AI Order Momentum Reshaping Its Core Life Sciences Investment Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T21:31:07+00:00", "published_display": "11 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TWST) as a Liquidity Pulse for Institutional Tactics", "summary": "This article, published on Stock Traders Daily, analyzes Twist Bioscience Corporation (NASDAQ: TWST) as a liquidity pulse for institutional tactics. It provides key findings including weak near-term sentiment but strong mid and long-term outlook, notes compelling upside potential", "url": "https://news.stocktradersdaily.com/news_release/39/TWST_as_a_Liquidity_Pulse_for_Institutional_Tactics_071026113401_1783697641.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T11:09:15", "published_display": "10 Jul 2026 11:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Twist Bioscience Corp For: 9 July By Investing.com", "summary": "The article an official Form 144 filing for Twist Bioscience Corp (TWST) on July 9, 2026. Form 144 is a notice of the intent to sell restricted securities. The brief article, published by Investing.com, serves as a record of this financial market activity.", "url": "https://ng.investing.com/news/stock-market-news/form-144-twist-bioscience-corp-for-9-july-93CH-2593745", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T22:40:04", "published_display": "09 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Officer reports multiple common stock sales (NASDAQ: TWST)", "summary": "A Form 144 filing by Twist Bioscience Corp (NASDAQ: TWST) indicates that officer Adam Laponis reported multiple sales of common stock between April and May 2026. The filing details specific share counts and proceeds for each transaction, and also mentions a planned security line ", "url": "https://www.stocktitan.net/sec-filings/TWST/144-twist-bioscience-corp-sec-filing-b6ceb7e4fdca.html", "source_name": "Stock Titan", "published_at": "2026-07-09T18:50:54", "published_display": "09 Jul 2026 18:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Raises its Price Target on Twist Bioscience (TWST)", "summary": "Evercore ISI recently downgraded Twist Bioscience (TWST) to 'In Line' from 'Outperform' but raised its price target to $102, citing a significant stock rally fueled by optimism around AI-driven order momentum. Other firms like Guggenheim and Barclays also increased their price ta", "url": "https://www.insidermonkey.com/blog/evercore-isi-raises-its-price-target-on-twist-bioscience-twst-1798520/", "source_name": "Insider Monkey", "published_at": "2026-07-09T10:50:54", "published_display": "09 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock falls as investors digest recent dilution risk and insider sale signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPVDd3ejVSbU1ROTdCTlVQVHAtRzhubjFZQVRqNHNBWGE2a0VUSFM4TVhIc1RHMmM0UjhFN0VLVFdNSmpROEM3S2hWckNZRmxldWNfWHBSWkx4MWdLdEVsM3ZfaS1BV210emZybFdYUjB1U3VxYmh2M3ZmYkpVYUlrQ3lfWGFlaGhqbU44alZxVks5S0lERDlSV2VYT1gwajRfbUVDT0dZYlI2SE9rdzJlcjRSWE04VlJVbHo2TnpaXzZlLWl0TFE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-07T21:20:00+00:00", "published_display": "07 Jul 2026 21:20", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102", "summary": "Evercore has downgraded its rating on Twist Bioscience (TWST.US) from Outperform to Hold. Despite the downgrade, the firm increased its price target for TWST.US to $102, up from the previous $90. This adjustment reflects Evercore's updated outlook on the company.", "url": "https://www.moomoo.com/news/post/72523962/evercore-downgrades-twist-bioscience-twstus-to-hold-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-07-06T16:10:41", "published_display": "06 Jul 2026 16:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Downgrades Twist Bioscience to In Line From Outperform, Price Target is $66", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-downgrades-twist-bioscience-121736613.html", "source_name": "MT Newswires", "published_at": "2026-07-06T12:17:36+00:00", "published_display": "06 Jul 2026 12:17", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investment bank Evercore ISI has adjusted its rating on biotechnology company Twist Bioscience Corp (TWST).", "summary": "Investment bank Evercore ISI has downgraded Twist Bioscience Corp (TWST) from \"outperform\" to \"neutral\" while significantly raising its target price from $66 to $102. This adjustment reflects a rebalancing of the bank's expectations for the company's short-term performance and lo", "url": "https://www.bitget.com/amp/news/detail/12560605491743", "source_name": "Bitget", "published_at": "2026-07-06T11:12:10", "published_display": "06 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST - Twist Bioscience Corp Options", "summary": "The article provides a snapshot of Twist Bioscience Corp (TWST) stock, detailing its latest close, financial performance metrics, and various technical and fundamental indicators. It includes information on market capitalization, income, sales, P/E ratios, employee count, and ins", "url": "https://finviz.com/stock?t=TWST&p=m&r=max&ty=oc&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-04T20:40:36", "published_display": "04 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Corp. Actuals & Estimates (SWB:0ME)", "summary": "This article provides an overview of Twist Bioscience Corp. (SWB:0ME) stock, including analyst forecasts, historical price data, and financial performance. It highlights key financial figures such as earnings per share and revenue for recent quarters, and notes that the company d", "url": "https://www.tradingview.com/symbols/SWB-0ME/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-07-03T01:40:48", "published_display": "03 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock hits 52-week high at 104.31 USD By Investing.com", "summary": "Twist Bioscience (TWST) stock reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is driven by strong investor confidence and positive analyst ratings, with several firms raising price targets due to the company's Q2 revenue beat an", "url": "https://ng.investing.com/news/stock-market-news/twist-bioscience-stock-hits-52week-high-at-10431-usd-93CH-2582683", "source_name": "Investing.com Nigeria", "published_at": "2026-07-02T08:09:54", "published_display": "02 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock hits 52-week high at 104.31 USD", "summary": "Twist Bioscience (TWST) stock has reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is attributed to positive market sentiment and strong analyst ratings, with several firms raising their price targets on the biotech company. Desp", "url": "https://www.investing.com/news/company-news/twist-bioscience-stock-hits-52week-high-at-10431-usd-93CH-4770861", "source_name": "Investing.com", "published_at": "2026-07-01T15:09:15", "published_display": "01 Jul 2026 15:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood\u2019s ARK sells Twist Bioscience, buys Circle Internet stock", "summary": "Cathie Wood's ARK ETFs made significant portfolio adjustments, selling over $11 million worth of Twist Bioscience stock while increasing holdings in Circle Internet Group Inc. and SoFi Technologies Inc. ARK also boosted its position in Recursion Pharmaceuticals Inc. but reduced i", "url": "https://www.investing.com/news/company-news/cathie-woods-ark-sells-twist-bioscience-buys-circle-internet-stock-93CH-4769278", "source_name": "Investing.com", "published_at": "2026-06-30T23:40:29", "published_display": "30 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood\u2019s ARK buys Coinbase, sells Twist Bioscience stock", "summary": "Cathie Wood's ARK ETFs made several strategic trades on June 29, 2026, significantly increasing its holdings in Coinbase Global Inc and Circle Internet Group Inc, and CoreWeave Inc, signaling continued confidence in digital assets and cloud computing. Conversely, ARK reduced its ", "url": "https://www.investing.com/news/company-news/cathie-woods-ark-buys-coinbase-sells-twist-bioscience-stock-93CH-4766750", "source_name": "Investing.com", "published_at": "2026-06-30T06:40:30", "published_display": "30 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Twist Bioscience\u2019s (TWST) New ATM Shelf Reshaping Its Capital Structure Or Just Adding Flexibility?", "summary": "Twist Bioscience (TWST) recently filed a universal shelf registration and an at-the-market (ATM) equity offering for up to US$200 million. This move provides the company with significant financial flexibility, which is crucial given its continued losses despite revenue growth. Th", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/is-twist-biosciences-twst-new-atm-shelf-reshaping-its-capita", "source_name": "Simply Wall Street", "published_at": "2026-06-30T03:11:47", "published_display": "30 Jun 2026 03:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Twist Bioscience Corporation \u2013 NASDAQ:TWST", "summary": "This article provides financial information for Twist Bioscience Corporation (NASDAQ: TWST) on TradingView. It specifically focuses on the company's price to earnings forward metric. The content includes general financial and market data, but not specific numeric values for the f", "url": "https://www.tradingview.com/symbols/NASDAQ-TWST/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:40:36", "published_display": "28 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Twist Bioscience Corp For: 26 June By Investing.com", "summary": "This article reports on a Form 4 filing for Twist Bioscience Corp, dated June 26, 2026. Form 4 filings disclose changes in ownership of company stock by insiders. The article includes the stock symbol TWST and its performance, but no further details about the filing itself.", "url": "https://ng.investing.com/news/stock-market-news/form-4-twist-bioscience-corp-for-26-june-93CH-2576545", "source_name": "Investing.com Nigeria", "published_at": "2026-06-27T17:40:36", "published_display": "27 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Stock Rises as Investors Continue to Reward Stronger Growth Outlook and Margin Progress", "summary": "Twist Bioscience (TWST) stock increased following an analyst's reiterated \"buy\" rating and price target increase, driven by improved growth and margin outlooks. The company is benefiting from increased demand in its Synthetic Biology segment and its next-generation sequencing pro", "url": "https://www.moomoo.com/news/post/72132720/twist-bioscience-stock-rises-as-investors-continue-to-reward-stronger", "source_name": "Moomoo", "published_at": "2026-06-27T06:40:30", "published_display": "27 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Twist Bioscience Corporation \u2013 NASDAQ:TWST", "summary": "This article provides a brief financial overview of Twist Bioscience Corporation (NASDAQ: TWST), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a section from a larger financial data platform like TradingView, offering a snapshot of a key va", "url": "https://www.tradingview.com/symbols/NASDAQ-TWST/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:56", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CEO Emily Leproust sells $1.79m in stock", "summary": "Emily M. Leproust, CEO of Twist Bioscience Corp (NASDAQ:TWST), sold $1.79 million worth of common stock on June 25, 2026, through a pre-established trading plan. This sale occurred while the stock was trading near its 52-week high, having surged 205% year-to-date. Despite the str", "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-ceo-emily-leproust-sells-179m-in-stock-93CH-4763553", "source_name": "Investing.com", "published_at": "2026-06-27T05:39:56", "published_display": "27 Jun 2026 05:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Insider Sold Shares Worth $1,793,600, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/twist-bioscience-insider-sold-shares-205017326.html", "source_name": "MT Newswires", "published_at": "2026-06-26T20:50:17+00:00", "published_display": "26 Jun 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) officer sells 14,205 shares in planned trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNdmpJMUQ4eHhWQW53S0V0alJJRHBKa1k4Wkh2ZktlTmRzbjluTDNMaG84WkpPUzFYNm02MDRxblFjbDNEWjNWSkI4cUExNlJpMmNtakFmNUhCTTZHRDhzZVRHWkJOQmc4MEFXMWVMNTFNeFVNZDRXSEJuZnB0Z01XZ3Y2MzVxdnEtakxmWnJrM200YUVhMDZCdmktWUhoVDRPRVRKdHAyNXhncFVxTkRnUXM1bmJKZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Multiple insider sales and a 346-share vesting at TWST (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOUEpCVnZ5am9FSXMxZm0yUFJwaHNpemtCQ0xVMW1JbUxlSEtPUzlhNHpQdzEtMmlJd3kzTllhRG9UQTBOWGVaQUFrb3VLbmJpVVl6eEo3a2JVbGVmWWpwT3E3VFNBb3dCbWRTQjFBUHlzMFBlWVMyLWRINnZjT0N6eUp0cUhsODJlTGpENzZwUmpBZUFHc1c1SVV6b3ZyUFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Emily Leproust sells TWST shares (NASDAQ: TWST) in multiple trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZzJnekV6YkRuZzZLWXJwNGdfRzFBOWFRbm14MnpWdlNNQWdRTk5uNFVlb1dKWEVSNFd0d1pFQV8tVThjMDdZbXV2aTdiMHhjLVlXM1BucVZJWjBzRGlxbWdjTHIwcHFldEpmck9IZzl3dXNRWWs2OE80SkNOSnNSd1lnQVlfd3RvU21NYzBMMkRabmNJdkx2TzlQenhXZFU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor\u2019s Favored Twist Bioscience\u2019s (TWST) Association with Technology Companies", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPN0tNV0pnYWVSdEdqRG9zb3lENy1fTGpXZl9MMm9pSFVWZTQ3Q0ZRVGJuOWI2dzFDMzByTHYwUkprNzZYcE5ULVJCb2QtYlhBd0JrY3lCS2RoX3VTeG95VU1TU3Y4SG91UHBRdzhWX0JOTUx3R0VWYzF0bzZzMkd1ZV8wSkNiZVNWSF84akEwRFA1WVZDQWVhNlFyUTVDNHY3?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Stock Looks 42.9% Overvalued After Bullish Analyst Calls", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience: Huge Downside, With Little Hope Of Profits (NASDAQ:TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOeHRYVk5CR1FrZWdsNjY1MjAtTkl1NUFGaFdobW5YdERjYm5haUZraE5YQXVybDNTQmdKOFNERFMwcjNOcG1sRVJXbVZqSWpyWXltbDZPZzlYek5jQ3VLajRlbGZiQVNtdkdzUkdfWUFfZGswOFFkZTJGTk9JOFE3OHlPcjF5a3BpaTRVR1o0eGVwbWZxQ0tIRVZBZXFHa2do?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) HR chief sells shares after exercising options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNbWphYU56WjJ6c0NabFhPU2tieWp5RmpkSEZzUjBkUzNmRlBBTHlyUGpEYTBCX0Nlbi1SS2FTZkl1UWZQeXVSTVliSlZpTEhfbWRhUE55cERWYmdzU215UzhTMkhXSkY1dUhna2gwZHczT3U1SjlEaHVHbXBSNUFZZGJ1aWJKM0VVcFZWYk5PbU1RWXRxVG1wdE5ZUE9pa2szQUhCYkVWaUhta0g0ZmJ6Yng5RXVVdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Stock Could Be 25.5% Overvalued After Its Recent Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZGNVODdfekZwNTEwSDhHSzhjbU1ZVjhOc1JmLU1Bb2RxNzg1U1ZsNFVLMGFTSnYzWXQzQ0VSdUJVM1Jvc3pJcFN0RzBIY0xlcmRNSllxemFxcEljR2ZiOFMwTjRlYjZTVmRveFVnZUhKMS01T1h2TTRyOV9BLV94NVdobHA1TmFDNnJPRGItOTB5RXZoZXdKOVlDZmxyV3M?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPVFVoNlhYWm00cUtjWWFxRlZlUnVuUGE0Qkxkdnhia1JvU0d4Zmljbk5QUzd3Mm1QejVRazlhQkZReW91Zk9PZjZXbmtHbko2Q0dObmJrRUtOTGFvZGNsME5JWk5KVzA4RTh0TWZieHZqb0lZaFAxRFdmalhOcnVXN0RKdzhTb2t5UFJmTTV3dVdiendTV3lsazJyOA?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Twist Bioscience (TWST) Is Evolving With Recent Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOaTNFdUFWeEVZcEI3NVJKVUFqRWl2TjFwVXpKZ1lHWEpXdDVGRHpDaEZ4S1hjZWhxc2NUZ2R2R3dLX2ZNYWhRZGtRVFp4ekoxSlF5VlBNMWQtaU1VY096dGpKTnY5NXMxZElEakYwMVNfeFo3QWhpRFZpZmM0eTZhcFJfZWZ1S0E1QkNpWk01ZE1KVnd3RVc3WW1Nb3NPYXFDUkNlTVR3?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) CEO Leproust sells 49,299 shares via 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOUzBSZGY4bVhLU2tjRGZvcTVkU2laNEp6LXowc254amlaaW5obTNiQ25NM2tWd2gwVDQ1WTB3M2x3OVoyRDJkY0ZKbGl4YUhqbk1Ra2RJR25fdE5iN2c2TG9PZkowQVBaZmxPLXktYjZlS2F5QnpaZ3RiaU5mX2NIUGZ4bVNRZUUxbER1VjdQZFVSMjRTanB5VmZTbFJfbUlwUFNyc2FOWS11TFJ1ZFdpanRQQWtLdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Affiliate files Form 144 to sell 500 shares of TWST (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOb2ZGQmRRd3BwQzFlaUVhRkhYdVZWUXEtcm1BRlZTbkZPN0xkcUZTSjBES0NpQlEwTlRHcklnZ0NxLVdvSFpwMkdSOU9fOXh1eGgyOTl0X3FJYUtaa3RCNHFRaUhkRFNjZlc4Uk9BbXRNczZJa0kwZ2pRSms1MEpnTGtnSTRPSEJCWlJEdm0xN0VBempKa0JvRjN3WExxVDQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adam Laponis files sale notice for TWST (NASDAQ: TWST) including recent trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONUI5X0F1aGZMZ1lqd01jTVJyaFRqc285YjF4bTBTazBQY2NMUnc5eXZWaXFpVDZVLUVvTndaVmxDQlVocFZEVzNJbkFUNi1wNEhQbjBkSDk4QlpKaVVncXZXaEtYeVNNeGZ3TGN6Q2pqWU5pZmdtb1MzYmt2OFhQVFFmSGhKS3UtZmhrNkNOSzFvTHp4dkwxUGxteGVGQVk?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (NASDAQ: TWST) insider files to sell 688 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZ2pTb1lWRy0wdW9HTWVaZ1FrVU9tSlZkUDdIYjE1RHZ1S19xQnhqX3VHVGZxTUxSbUVOZW9fbHM2TElvdURtbS1NS0tLZHhIU29ISGNRZGFaNXhIRV81T2M3YjBLOXVZa0E3UnFGT1Zjc2JSNEV0dTBBZ0NxMlIycUJ1ckF5OG13Z2E5UEt1WlVKUDc3OUcxLVFfSjgycG8?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Twist Bioscience Q2 2026 EPS miss, stock rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNcy1KaDQtVzJIamxwTFNpblJrS051WmtVcm1ib19STjF1eHNwSFNSM0NkRDN5YTZwNGlUWTVyWHpSR0RNTXo4RU9DYjNUUGk0anRQWXdCV1pxTUUxYTRLWjBFS1Q0Tm45Sk5kdGppbzFVUVNzUXVlQUVNZ2ExNWxCak5PWHlkRXN3U1NqWDNNcDVvVDBtUUVvaUFid1hIdDhhcnZiLUl0UTJrRkNkdnpKM0pxcWtTd0pRYVUtS1pIUHhfTzhf?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ARK Investment Management reports 10.35% stake in Twist Bioscience (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQOW1iay1XaGNMOFpHTjYzdEU5QlJEemwycFNEb0ZvQXBsakRRX0lObGp6bDJwVWx2N3dZNVNTWGpKV0t3RDNzTkp6a2t1MFVPSFMzeGhuVWlMWnI3STNfNnNVTEJZbmtiM2RtdXJHRDhzMjBkal9GeGpBNjdxTWRJMGpwS0o4cUZaTFpWd2t2cHM4bzZ0b1FfREJVaV9uQ3VQNG54cktjZGhJY2o4WTc5MGhjVThYNUVRSXlsTnJLQ0RmRWs3YnBHWVVoMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "500-share sale listed; TWST (NASDAQ: TWST) Form 144 notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMWh5S2R6WWtvU2lVelZVcVBpS0pzQXN6VVZ0WDNJRjFkQ0liYkFuSlF4OUp3TlJqNXpndC1kYndBV3FfQi1vSG8wamlWRjY5WkQyNHhULVZTbnNnUVZPUnc5QXd0RTFqOG0xdDhZR1c0MEhFMlRJN0NCbHY2LXpYY2phbDJhaENwazgydzRmcXV5UjFLNDVPYW5WemtXUUU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Emily Leproust sells multiple TWST shares (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUTlmdHFaSW9NbExCNE1aTTM5UHNrWWtiX1pvdjY4emdzbk5MN041amFITThyMkI5RXZ0SzBGekhRd05neDJmWGhwWERySE9VWjdjbHdoeGRvblkxV0RlZlZWZXkzQlU5TWVDVEFNTGlWX3htNERDT3FNZEZHZ0dZX0oteWVOTGs2UlFfSlJsalROSGM2UE9vZXp6SEZiVXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider share sales disclosed \u2014 Company (NASDAQ: TWST) lists recent dispositions", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQd0VOLXhlTjNEZFlaR2FIVEI1amtlTnBMS2ttaThZUWE3WlZSakFCZ0NZSHZYbU05MjlQQXVTdFFKWG1SVEhEYjNDYWc1M0w3NmpNRDQya1BwcUtvSjJlRXNFTnNvMndkN2FkdlVMUTBzZC1Vc1JnU041U0pvZXRlb3RsT18xUDRVRDNQZndlSzdjUGVlbTF0Ty1SOVNXNEU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Corporation (NASDAQ:TWST) Held Back By Insufficient Growth Even After Shares Climb 30%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxPN0JsM1NEM1Vld2ZSUFlRa195eFlSRU54ZDFrWV9uRjRJcU16YWlpMEoyNW1idzRnZDNpVmNJbGFvLVg3SGtUd292YTZIc05BaDYwUnkyMi1DZEZfWVllNEJ2X1F1bEU1NzVvWi16Rmtad0EtWjdTeUE0LURFZnBfWGRkQ0tSNlBXSTR2M2dXQVUxbVpDMVlvOXBqLXllVmd0ZmE1Vjl2aVB3M3dDSGhEVWV3VENjVnR3TTNuNzBsVDA5d2NiQ0t2QXZ0bFhEVkdlM0I1d0N1b2RDaXBON1VNU0UybkVwcUHSAewBQVVfeXFMTk03WDlTdkx4eUpXRW9vSnBtVEdtVU5YYVNYQ0FzazNrVmRQSmJkNlRVU3NDMjFnc09YeHI4a1plS2piOVNRRnRjS0JGeWlwbU5DYTN3Q2Z6NjJ5Q2pkTFZDTGJzWU1XTmFnWldMQ0lkaXJPclpBOGdid1hfbGRCTy1vRzBaOFVQUzQ3S1FYODNzRXIxdnB0RXlzenRkamtUak1NdGJicjJoSzVSRnNMdXAteldKc3JGX2lodUVxQW5rR05CRFhHRDNWc29mVFlEQkotQkV3Z18zekREV3A1SXlvWmJVYjk3WUxlQ3c?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Twist Bioscience Corp. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE9ldVpEVUFwWk5jdGozNVBNSjVWUU1NNGp2VWtHMnUzalhhUl8zYS1BR3BXeWMzRnNGUmppd01VLUt2bXJNSDhpRHpCaFVfbGhJVndlSVdPdE4xcjRoM01ZOXFsWQ?oc=5", "source_name": "TradingView", "published_at": "2025-09-23T15:08:42+00:00", "published_display": "23 Sep 2025 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Twist Bioscience Is Maintained at Buy by Canaccord Genuity", "summary": "Canaccord Genuity has maintained its \"Buy\" rating for Twist Bioscience (TWST). The article briefly mentions unrelated fourth-quarter financial results for Unity Software, which exceeded revenue estimates but reported a loss per share.", "url": "https://www.moomoo.com/news/post/72935284/twist-bioscience-is-maintained-at-buy-by-canaccord-genuity", "source_name": "Moomoo", "published_at": "2026-07-15T14:46:43", "published_display": "15 Jul 2026 14:46", "sentiment": "positive", "sentiment_pct": 69, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience plans 8 a.m. ET call for fiscal Q3 update", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOd0ZkWmNRZVREUnFxQW5iU1BVYmlDaEtucmU1cUpQUC1Fb05QU0dkUW54dHFXQkpvMjYtWE1NV3ZkYzdCSm9ZQ0tGR2pHLXNpX2JsVTFfbUE3TmhDZU1HSlhlRVBSQTJETml1MFVBSzRtX0M5TWhNQjdxQ1NLVE41aTlOWlM4OG4zYXZlb2J6cGY5T3lqRmNEem14OGs3ak1SRURfWUJLLXMyMjNkei02YVV6WFU3SU5D?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T12:00:00+00:00", "published_display": "15 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026", "summary": "Twist Bioscience Corporation (NASDAQ: TWST) announced it will release its fiscal 2026 third-quarter financial results before market open on August 3, 2026. The company will also host a conference call and live audio webcast for analysts and investors at 8:00 AM ET on the same day", "url": "https://sg.finance.yahoo.com/news/twist-bioscience-report-fiscal-2026-120000638.html", "source_name": "Market source", "published_at": "2026-07-15T11:46:43", "published_display": "15 Jul 2026 11:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST Maintained by Canaccord Genuity -- Price Target Raised to $120", "summary": "Canaccord Genuity maintained a 'Buy' rating for Twist Bioscience (TWST) and raised its price target to $120, citing a positive outlook on the company's growth potential despite its current overvalued status according to GuruFocus. While analysts are optimistic due to Twist Biosci", "url": "https://www.gurufocus.com/news/8957540/twst-maintained-by-canaccord-genuity-price-target-raised-to-120", "source_name": "GuruFocus", "published_at": "2026-07-14T13:41:07", "published_display": "14 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 63, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CFO Adam Laponis sells $226,307 in stock By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPN21EaFVhY2U1V0Z2ZHpZYmZzMzUwbFRFb3lYeU1EWkg5SE1BaDVaQlhUYm5JS0NTOW9jSWp4cncyZDNDSXFnQlptTzc5ekg5Nm53V2VPdW1yc3FZQ1pCWFIwRnZYT0xqT0dWZzRoLS16UHJkSFVwTkJFX3QtajhpbndhYTRGcEhrTFRheU5ZbldqSE5CaUR1c2ZhNmd5NEZzVTZ5YkhTZWc4TGJjNGRndjVBLTdfUk0?oc=5", "source_name": "Investing.com South Africa", "published_at": "2026-07-13T21:41:47+00:00", "published_display": "13 Jul 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Twist Bioscience Corp Insider Trading Activity", "summary": "Twist Bioscience Corp's CFO, Adam Laponis, sold 2,399 shares of common stock on July 9, 2026, for $94.334 per share. This \"sell to cover\" transaction was mandatory to meet tax withholding obligations from vesting Restricted Stock Units, not a discretionary sale. Following the sal", "url": "https://www.stocktitan.net/sec-filings/TWST/form-4-twist-bioscience-corp-insider-trading-activity-5f5f896b5d1f.html", "source_name": "Stock Titan", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CFO Adam Laponis sells $226,307 in stock", "summary": "Twist Bioscience CFO Adam Laponis sold $226,307 worth of company stock to cover tax obligations related to Restricted Stock Units, not as a discretionary trade. This transaction occurred as the stock experienced a 9.3% decline over the past week and is considered overvalued by In", "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-cfo-adam-laponis-sells-226307-in-stock-93CH-4789172", "source_name": "Investing.com", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Twist Bioscience Corp For: 13 July By Investing.com", "summary": "This article reports on a Form 4 filing for Twist Bioscience Corp (TWST) on July 13. Form 4 filings are used to report changes in beneficial ownership of company stock by insiders. The article provides the date of the filing and mentions Twist Bioscience Corp's stock symbol.", "url": "https://ca.investing.com/news/stock-market-news/form-4-twist-bioscience-corp-for-13-july-93CH-4731757", "source_name": "Investing.com Canada", "published_at": "2026-07-13T20:11:10", "published_display": "13 Jul 2026 20:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) price target increased by 20.55% to 64.90", "summary": "This article reports a significant increase in Twist Bioscience's (TWST) price target. The target has been raised by 20.55% to $64.90.", "url": "http://www.msn.com/en-us/money/top-stocks/twist-bioscience-twst-price-target-increased-by-20-55-to-64-90/ar-AA23cZSC?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-11T22:40:50", "published_display": "11 Jul 2026 22:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Twist Bioscience\u2019s (TWST) AI Order Momentum Reshaping Its Core Life Sciences Investment Story?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-11T21:31:07+00:00", "published_display": "11 Jul 2026 21:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(TWST) as a Liquidity Pulse for Institutional Tactics", "summary": "This article, published on Stock Traders Daily, analyzes Twist Bioscience Corporation (NASDAQ: TWST) as a liquidity pulse for institutional tactics. It provides key findings including weak near-term sentiment but strong mid and long-term outlook, notes compelling upside potential", "url": "https://news.stocktradersdaily.com/news_release/39/TWST_as_a_Liquidity_Pulse_for_Institutional_Tactics_071026113401_1783697641.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T11:09:15", "published_display": "10 Jul 2026 11:09", "sentiment": "positive", "sentiment_pct": 62, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Twist Bioscience Corp For: 9 July By Investing.com", "summary": "The article an official Form 144 filing for Twist Bioscience Corp (TWST) on July 9, 2026. Form 144 is a notice of the intent to sell restricted securities. The brief article, published by Investing.com, serves as a record of this financial market activity.", "url": "https://ng.investing.com/news/stock-market-news/form-144-twist-bioscience-corp-for-9-july-93CH-2593745", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T22:40:04", "published_display": "09 Jul 2026 22:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Officer reports multiple common stock sales (NASDAQ: TWST)", "summary": "A Form 144 filing by Twist Bioscience Corp (NASDAQ: TWST) indicates that officer Adam Laponis reported multiple sales of common stock between April and May 2026. The filing details specific share counts and proceeds for each transaction, and also mentions a planned security line ", "url": "https://www.stocktitan.net/sec-filings/TWST/144-twist-bioscience-corp-sec-filing-b6ceb7e4fdca.html", "source_name": "Stock Titan", "published_at": "2026-07-09T18:50:54", "published_display": "09 Jul 2026 18:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Raises its Price Target on Twist Bioscience (TWST)", "summary": "Evercore ISI recently downgraded Twist Bioscience (TWST) to 'In Line' from 'Outperform' but raised its price target to $102, citing a significant stock rally fueled by optimism around AI-driven order momentum. Other firms like Guggenheim and Barclays also increased their price ta", "url": "https://www.insidermonkey.com/blog/evercore-isi-raises-its-price-target-on-twist-bioscience-twst-1798520/", "source_name": "Insider Monkey", "published_at": "2026-07-09T10:50:54", "published_display": "09 Jul 2026 10:50", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock falls as investors digest recent dilution risk and insider sale signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPVDd3ejVSbU1ROTdCTlVQVHAtRzhubjFZQVRqNHNBWGE2a0VUSFM4TVhIc1RHMmM0UjhFN0VLVFdNSmpROEM3S2hWckNZRmxldWNfWHBSWkx4MWdLdEVsM3ZfaS1BV210emZybFdYUjB1U3VxYmh2M3ZmYkpVYUlrQ3lfWGFlaGhqbU44alZxVks5S0lERDlSV2VYT1gwajRfbUVDT0dZYlI2SE9rdzJlcjRSWE04VlJVbHo2TnpaXzZlLWl0TFE?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-07T21:20:00+00:00", "published_display": "07 Jul 2026 21:20", "sentiment": "negative", "sentiment_pct": 6, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore Downgrades Twist Bioscience(TWST.US) to Hold Rating, Raises Target Price to $102", "summary": "Evercore has downgraded its rating on Twist Bioscience (TWST.US) from Outperform to Hold. Despite the downgrade, the firm increased its price target for TWST.US to $102, up from the previous $90. This adjustment reflects Evercore's updated outlook on the company.", "url": "https://www.moomoo.com/news/post/72523962/evercore-downgrades-twist-bioscience-twstus-to-hold-rating-raises-target", "source_name": "Moomoo", "published_at": "2026-07-06T16:10:41", "published_display": "06 Jul 2026 16:10", "sentiment": "negative", "sentiment_pct": 30, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evercore ISI Downgrades Twist Bioscience to In Line From Outperform, Price Target is $66", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/evercore-isi-downgrades-twist-bioscience-121736613.html", "source_name": "MT Newswires", "published_at": "2026-07-06T12:17:36+00:00", "published_display": "06 Jul 2026 12:17", "sentiment": "positive", "sentiment_pct": 58, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investment bank Evercore ISI has adjusted its rating on biotechnology company Twist Bioscience Corp (TWST).", "summary": "Investment bank Evercore ISI has downgraded Twist Bioscience Corp (TWST) from \"outperform\" to \"neutral\" while significantly raising its target price from $66 to $102. This adjustment reflects a rebalancing of the bank's expectations for the company's short-term performance and lo", "url": "https://www.bitget.com/amp/news/detail/12560605491743", "source_name": "Bitget", "published_at": "2026-07-06T11:12:10", "published_display": "06 Jul 2026 11:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST - Twist Bioscience Corp Options", "summary": "The article provides a snapshot of Twist Bioscience Corp (TWST) stock, detailing its latest close, financial performance metrics, and various technical and fundamental indicators. It includes information on market capitalization, income, sales, P/E ratios, employee count, and ins", "url": "https://finviz.com/stock?t=TWST&p=m&r=max&ty=oc&ov=chain_strike&s=25", "source_name": "Finviz", "published_at": "2026-07-04T20:40:36", "published_display": "04 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Corp. Actuals & Estimates (SWB:0ME)", "summary": "This article provides an overview of Twist Bioscience Corp. (SWB:0ME) stock, including analyst forecasts, historical price data, and financial performance. It highlights key financial figures such as earnings per share and revenue for recent quarters, and notes that the company d", "url": "https://www.tradingview.com/symbols/SWB-0ME/forecast-actuals-and-estimates/?category=balance_sheet", "source_name": "TradingView", "published_at": "2026-07-03T01:40:48", "published_display": "03 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock hits 52-week high at 104.31 USD By Investing.com", "summary": "Twist Bioscience (TWST) stock reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is driven by strong investor confidence and positive analyst ratings, with several firms raising price targets due to the company's Q2 revenue beat an", "url": "https://ng.investing.com/news/stock-market-news/twist-bioscience-stock-hits-52week-high-at-10431-usd-93CH-2582683", "source_name": "Investing.com Nigeria", "published_at": "2026-07-02T08:09:54", "published_display": "02 Jul 2026 08:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience stock hits 52-week high at 104.31 USD", "summary": "Twist Bioscience (TWST) stock has reached a new 52-week high of $104.31, reflecting a 175.61% increase over the past year. This surge is attributed to positive market sentiment and strong analyst ratings, with several firms raising their price targets on the biotech company. Desp", "url": "https://www.investing.com/news/company-news/twist-bioscience-stock-hits-52week-high-at-10431-usd-93CH-4770861", "source_name": "Investing.com", "published_at": "2026-07-01T15:09:15", "published_display": "01 Jul 2026 15:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood\u2019s ARK sells Twist Bioscience, buys Circle Internet stock", "summary": "Cathie Wood's ARK ETFs made significant portfolio adjustments, selling over $11 million worth of Twist Bioscience stock while increasing holdings in Circle Internet Group Inc. and SoFi Technologies Inc. ARK also boosted its position in Recursion Pharmaceuticals Inc. but reduced i", "url": "https://www.investing.com/news/company-news/cathie-woods-ark-sells-twist-bioscience-buys-circle-internet-stock-93CH-4769278", "source_name": "Investing.com", "published_at": "2026-06-30T23:40:29", "published_display": "30 Jun 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cathie Wood\u2019s ARK buys Coinbase, sells Twist Bioscience stock", "summary": "Cathie Wood's ARK ETFs made several strategic trades on June 29, 2026, significantly increasing its holdings in Coinbase Global Inc and Circle Internet Group Inc, and CoreWeave Inc, signaling continued confidence in digital assets and cloud computing. Conversely, ARK reduced its ", "url": "https://www.investing.com/news/company-news/cathie-woods-ark-buys-coinbase-sells-twist-bioscience-stock-93CH-4766750", "source_name": "Investing.com", "published_at": "2026-06-30T06:40:30", "published_display": "30 Jun 2026 06:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Twist Bioscience\u2019s (TWST) New ATM Shelf Reshaping Its Capital Structure Or Just Adding Flexibility?", "summary": "Twist Bioscience (TWST) recently filed a universal shelf registration and an at-the-market (ATM) equity offering for up to US$200 million. This move provides the company with significant financial flexibility, which is crucial given its continued losses despite revenue growth. Th", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-twst/twist-bioscience/news/is-twist-biosciences-twst-new-atm-shelf-reshaping-its-capita", "source_name": "Simply Wall Street", "published_at": "2026-06-30T03:11:47", "published_display": "30 Jun 2026 03:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Twist Bioscience Corporation \u2013 NASDAQ:TWST", "summary": "This article provides financial information for Twist Bioscience Corporation (NASDAQ: TWST) on TradingView. It specifically focuses on the company's price to earnings forward metric. The content includes general financial and market data, but not specific numeric values for the f", "url": "https://www.tradingview.com/symbols/NASDAQ-TWST/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:40:36", "published_display": "28 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Twist Bioscience Corp For: 26 June By Investing.com", "summary": "This article reports on a Form 4 filing for Twist Bioscience Corp, dated June 26, 2026. Form 4 filings disclose changes in ownership of company stock by insiders. The article includes the stock symbol TWST and its performance, but no further details about the filing itself.", "url": "https://ng.investing.com/news/stock-market-news/form-4-twist-bioscience-corp-for-26-june-93CH-2576545", "source_name": "Investing.com Nigeria", "published_at": "2026-06-27T17:40:36", "published_display": "27 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Stock Rises as Investors Continue to Reward Stronger Growth Outlook and Margin Progress", "summary": "Twist Bioscience (TWST) stock increased following an analyst's reiterated \"buy\" rating and price target increase, driven by improved growth and margin outlooks. The company is benefiting from increased demand in its Synthetic Biology segment and its next-generation sequencing pro", "url": "https://www.moomoo.com/news/post/72132720/twist-bioscience-stock-rises-as-investors-continue-to-reward-stronger", "source_name": "Moomoo", "published_at": "2026-06-27T06:40:30", "published_display": "27 Jun 2026 06:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Twist Bioscience Corporation \u2013 NASDAQ:TWST", "summary": "This article provides a brief financial overview of Twist Bioscience Corporation (NASDAQ: TWST), specifically focusing on its forward price-to-sales ratio. It appears to be a stub or a section from a larger financial data platform like TradingView, offering a snapshot of a key va", "url": "https://www.tradingview.com/symbols/NASDAQ-TWST/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T05:39:56", "published_display": "27 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience CEO Emily Leproust sells $1.79m in stock", "summary": "Emily M. Leproust, CEO of Twist Bioscience Corp (NASDAQ:TWST), sold $1.79 million worth of common stock on June 25, 2026, through a pre-established trading plan. This sale occurred while the stock was trading near its 52-week high, having surged 205% year-to-date. Despite the str", "url": "https://www.investing.com/news/insider-trading-news/twist-bioscience-ceo-emily-leproust-sells-179m-in-stock-93CH-4763553", "source_name": "Investing.com", "published_at": "2026-06-27T05:39:56", "published_display": "27 Jun 2026 05:39", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Insider Sold Shares Worth $1,793,600, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/twist-bioscience-insider-sold-shares-205017326.html", "source_name": "MT Newswires", "published_at": "2026-06-26T20:50:17+00:00", "published_display": "26 Jun 2026 20:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) officer sells 14,205 shares in planned trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNdmpJMUQ4eHhWQW53S0V0alJJRHBKa1k4Wkh2ZktlTmRzbjluTDNMaG84WkpPUzFYNm02MDRxblFjbDNEWjNWSkI4cUExNlJpMmNtakFmNUhCTTZHRDhzZVRHWkJOQmc4MEFXMWVMNTFNeFVNZDRXSEJuZnB0Z01XZ3Y2MzVxdnEtakxmWnJrM200YUVhMDZCdmktWUhoVDRPRVRKdHAyNXhncFVxTkRnUXM1bmJKZw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-26T07:00:00+00:00", "published_display": "26 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Multiple insider sales and a 346-share vesting at TWST (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOUEpCVnZ5am9FSXMxZm0yUFJwaHNpemtCQ0xVMW1JbUxlSEtPUzlhNHpQdzEtMmlJd3kzTllhRG9UQTBOWGVaQUFrb3VLbmJpVVl6eEo3a2JVbGVmWWpwT3E3VFNBb3dCbWRTQjFBUHlzMFBlWVMyLWRINnZjT0N6eUp0cUhsODJlTGpENzZwUmpBZUFHc1c1SVV6b3ZyUFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Emily Leproust sells TWST shares (NASDAQ: TWST) in multiple trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZzJnekV6YkRuZzZLWXJwNGdfRzFBOWFRbm14MnpWdlNNQWdRTk5uNFVlb1dKWEVSNFd0d1pFQV8tVThjMDdZbXV2aTdiMHhjLVlXM1BucVZJWjBzRGlxbWdjTHIwcHFldEpmck9IZzl3dXNRWWs2OE80SkNOSnNSd1lnQVlfd3RvU21NYzBMMkRabmNJdkx2TzlQenhXZFU?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor\u2019s Favored Twist Bioscience\u2019s (TWST) Association with Technology Companies", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPN0tNV0pnYWVSdEdqRG9zb3lENy1fTGpXZl9MMm9pSFVWZTQ3Q0ZRVGJuOWI2dzFDMzByTHYwUkprNzZYcE5ULVJCb2QtYlhBd0JrY3lCS2RoX3VTeG95VU1TU3Y4SG91UHBRdzhWX0JOTUx3R0VWYzF0bzZzMkd1ZV8wSkNiZVNWSF84akEwRFA1WVZDQWVhNlFyUTVDNHY3?oc=5", "source_name": "Market source", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Stock Looks 42.9% Overvalued After Bullish Analyst Calls", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience: Huge Downside, With Little Hope Of Profits (NASDAQ:TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOeHRYVk5CR1FrZWdsNjY1MjAtTkl1NUFGaFdobW5YdERjYm5haUZraE5YQXVybDNTQmdKOFNERFMwcjNOcG1sRVJXbVZqSWpyWXltbDZPZzlYek5jQ3VLajRlbGZiQVNtdkdzUkdfWUFfZGswOFFkZTJGTk9JOFE3OHlPcjF5a3BpaTRVR1o0eGVwbWZxQ0tIRVZBZXFHa2do?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) HR chief sells shares after exercising options", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNbWphYU56WjJ6c0NabFhPU2tieWp5RmpkSEZzUjBkUzNmRlBBTHlyUGpEYTBCX0Nlbi1SS2FTZkl1UWZQeXVSTVliSlZpTEhfbWRhUE55cERWYmdzU215UzhTMkhXSkY1dUhna2gwZHczT3U1SjlEaHVHbXBSNUFZZGJ1aWJKM0VVcFZWYk5PbU1RWXRxVG1wdE5ZUE9pa2szQUhCYkVWaUhta0g0ZmJ6Yng5RXVVdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Stock Could Be 25.5% Overvalued After Its Recent Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZGNVODdfekZwNTEwSDhHSzhjbU1ZVjhOc1JmLU1Bb2RxNzg1U1ZsNFVLMGFTSnYzWXQzQ0VSdUJVM1Jvc3pJcFN0RzBIY0xlcmRNSllxemFxcEljR2ZiOFMwTjRlYjZTVmRveFVnZUhKMS01T1h2TTRyOV9BLV94NVdobHA1TmFDNnJPRGItOTB5RXZoZXdKOVlDZmxyV3M?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPVFVoNlhYWm00cUtjWWFxRlZlUnVuUGE0Qkxkdnhia1JvU0d4Zmljbk5QUzd3Mm1QejVRazlhQkZReW91Zk9PZjZXbmtHbko2Q0dObmJrRUtOTGFvZGNsME5JWk5KVzA4RTh0TWZieHZqb0lZaFAxRFdmalhOcnVXN0RKdzhTb2t5UFJmTTV3dVdiendTV3lsazJyOA?oc=5", "source_name": "Market source", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Investment Story For Twist Bioscience (TWST) Is Evolving With Recent Developments", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOaTNFdUFWeEVZcEI3NVJKVUFqRWl2TjFwVXpKZ1lHWEpXdDVGRHpDaEZ4S1hjZWhxc2NUZ2R2R3dLX2ZNYWhRZGtRVFp4ekoxSlF5VlBNMWQtaU1VY096dGpKTnY5NXMxZElEakYwMVNfeFo3QWhpRFZpZmM0eTZhcFJfZWZ1S0E1QkNpWk01ZE1KVnd3RVc3WW1Nb3NPYXFDUkNlTVR3?oc=5", "source_name": "Market source", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (TWST) CEO Leproust sells 49,299 shares via 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOUzBSZGY4bVhLU2tjRGZvcTVkU2laNEp6LXowc254amlaaW5obTNiQ25NM2tWd2gwVDQ1WTB3M2x3OVoyRDJkY0ZKbGl4YUhqbk1Ra2RJR25fdE5iN2c2TG9PZkowQVBaZmxPLXktYjZlS2F5QnpaZ3RiaU5mX2NIUGZ4bVNRZUUxbER1VjdQZFVSMjRTanB5VmZTbFJfbUlwUFNyc2FOWS11TFJ1ZFdpanRQQWtLdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Affiliate files Form 144 to sell 500 shares of TWST (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOb2ZGQmRRd3BwQzFlaUVhRkhYdVZWUXEtcm1BRlZTbkZPN0xkcUZTSjBES0NpQlEwTlRHcklnZ0NxLVdvSFpwMkdSOU9fOXh1eGgyOTl0X3FJYUtaa3RCNHFRaUhkRFNjZlc4Uk9BbXRNczZJa0kwZ2pRSms1MEpnTGtnSTRPSEJCWlJEdm0xN0VBempKa0JvRjN3WExxVDQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adam Laponis files sale notice for TWST (NASDAQ: TWST) including recent trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxONUI5X0F1aGZMZ1lqd01jTVJyaFRqc285YjF4bTBTazBQY2NMUnc5eXZWaXFpVDZVLUVvTndaVmxDQlVocFZEVzNJbkFUNi1wNEhQbjBkSDk4QlpKaVVncXZXaEtYeVNNeGZ3TGN6Q2pqWU5pZmdtb1MzYmt2OFhQVFFmSGhKS3UtZmhrNkNOSzFvTHp4dkwxUGxteGVGQVk?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience (NASDAQ: TWST) insider files to sell 688 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOZ2pTb1lWRy0wdW9HTWVaZ1FrVU9tSlZkUDdIYjE1RHZ1S19xQnhqX3VHVGZxTUxSbUVOZW9fbHM2TElvdURtbS1NS0tLZHhIU29ISGNRZGFaNXhIRV81T2M3YjBLOXVZa0E3UnFGT1Zjc2JSNEV0dTBBZ0NxMlIycUJ1ckF5OG13Z2E5UEt1WlVKUDc3OUcxLVFfSjgycG8?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: Twist Bioscience Q2 2026 EPS miss, stock rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNcy1KaDQtVzJIamxwTFNpblJrS051WmtVcm1ib19STjF1eHNwSFNSM0NkRDN5YTZwNGlUWTVyWHpSR0RNTXo4RU9DYjNUUGk0anRQWXdCV1pxTUUxYTRLWjBFS1Q0Tm45Sk5kdGppbzFVUVNzUXVlQUVNZ2ExNWxCak5PWHlkRXN3U1NqWDNNcDVvVDBtUUVvaUFid1hIdDhhcnZiLUl0UTJrRkNkdnpKM0pxcWtTd0pRYVUtS1pIUHhfTzhf?oc=5", "source_name": "Investing.com", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ARK Investment Management reports 10.35% stake in Twist Bioscience (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQOW1iay1XaGNMOFpHTjYzdEU5QlJEemwycFNEb0ZvQXBsakRRX0lObGp6bDJwVWx2N3dZNVNTWGpKV0t3RDNzTkp6a2t1MFVPSFMzeGhuVWlMWnI3STNfNnNVTEJZbmtiM2RtdXJHRDhzMjBkal9GeGpBNjdxTWRJMGpwS0o4cUZaTFpWd2t2cHM4bzZ0b1FfREJVaV9uQ3VQNG54cktjZGhJY2o4WTc5MGhjVThYNUVRSXlsTnJLQ0RmRWs3YnBHWVVoMA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "500-share sale listed; TWST (NASDAQ: TWST) Form 144 notice", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNMWh5S2R6WWtvU2lVelZVcVBpS0pzQXN6VVZ0WDNJRjFkQ0liYkFuSlF4OUp3TlJqNXpndC1kYndBV3FfQi1vSG8wamlWRjY5WkQyNHhULVZTbnNnUVZPUnc5QXd0RTFqOG0xdDhZR1c0MEhFMlRJN0NCbHY2LXpYY2phbDJhaENwazgydzRmcXV5UjFLNDVPYW5WemtXUUU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Emily Leproust sells multiple TWST shares (NASDAQ: TWST)", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPUTlmdHFaSW9NbExCNE1aTTM5UHNrWWtiX1pvdjY4emdzbk5MN041amFITThyMkI5RXZ0SzBGekhRd05neDJmWGhwWERySE9VWjdjbHdoeGRvblkxV0RlZlZWZXkzQlU5TWVDVEFNTGlWX3htNERDT3FNZEZHZ0dZX0oteWVOTGs2UlFfSlJsalROSGM2UE9vZXp6SEZiVXc?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider share sales disclosed \u2014 Company (NASDAQ: TWST) lists recent dispositions", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQd0VOLXhlTjNEZFlaR2FIVEI1amtlTnBMS2ttaThZUWE3WlZSakFCZ0NZSHZYbU05MjlQQXVTdFFKWG1SVEhEYjNDYWc1M0w3NmpNRDQya1BwcUtvSjJlRXNFTnNvMndkN2FkdlVMUTBzZC1Vc1JnU041U0pvZXRlb3RsT18xUDRVRDNQZndlSzdjUGVlbTF0Ty1SOVNXNEU?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Expands Antibody Discovery With Invenra Bispecific Platform Deal", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Twist Bioscience Corporation (NASDAQ:TWST) Held Back By Insufficient Growth Even After Shares Climb 30%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-14T08:00:00+00:00", "published_display": "14 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ETFs Investing in Twist Bioscience Corp. Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiY0FVX3lxTE9ldVpEVUFwWk5jdGozNVBNSjVWUU1NNGp2VWtHMnUzalhhUl8zYS1BR3BXeWMzRnNGUmppd01VLUt2bXJNSDhpRHpCaFVfbGhJVndlSVdPdE4xcjRoM01ZOXFsWQ?oc=5", "source_name": "TradingView", "published_at": "2025-09-23T15:08:42+00:00", "published_display": "23 Sep 2025 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 101, "total_relevant": 53, "sentiment_summary": {"positive": 13, "negative": 9, "neutral": 31, "score": 52, "total": 53, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 19.05, "count": 34}, {"event": "analyst", "label": "Analyst action", "weight": 4.95, "count": 9}, {"event": "earnings", "label": "Earnings", "weight": 3.85, "count": 7}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 9}, "market_context": {"has_market_context": true, "latest_close": 90.64, "latest_week": "2026-07-10", "one_week_move": -8.7, "four_week_move": 19.0, "twelve_week_move": 51.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.883706, "market_dynamics_buy_signal": false, "relative_strength": 78.202879, "fair_value_gap": 128.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 46.9008, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-8.7% over one week, +19.0% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 15}, {"label": "Investing.com", "count": 6}, {"label": "Market source", "count": 5}, {"label": "simplywall.st", "count": 4}, {"label": "TradingView", "count": 4}, {"label": "Moomoo", "count": 3}, {"label": "Investing.com Nigeria", "count": 3}, {"label": "MT Newswires", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 53}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Analyst action", "count": 9}, {"label": "Earnings", "count": 7}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "53", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-8.7% over one week, +19.0% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Twist Bioscience Is Maintained at Buy by Canaccord Genuity"}], "updated_at": "2026-07-16T08:07:36.578324+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}